Evry, France

Denis Simonin



 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2011-2018

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Denis Simonin: Innovator in Capillary Electrophoresis

Introduction

Denis Simonin is a prominent inventor based in Evry, France, recognized for his significant contributions to the field of biochemistry through his innovative methods of analysis. With a total of four patents, Simonin is making strides in the critical area of glycated hemoglobins, which play an essential role in medical diagnostics.

Latest Patents

Simonin's latest patents focus on the analysis and assay of glycated hemoglobins by capillary electrophoresis. His invention describes a method that involves analyzing glycated hemoglobins containing a glucose residue tied to an amino acid in the N-terminal position. This method employs a unique buffer composition containing compounds that specifically complex glucose residues, allowing glycated hemoglobins to gain multiple negative electric charges under alkaline pH conditions. Notably, one example of such a compound is 3,5-dicarboxyphenylboronic acid. The approach not only enhances the separation and assay of hemoglobin A but also accommodates biological samples that include other hemoglobin fractions.

Career Highlights

Simonin is associated with Sebia, a leading company specializing in the development of diagnostic solutions. His work has driven advancements in patient care by enabling more accurate monitoring of glycated hemoglobins, which are vital indicators in diabetes management.

Collaborations

Throughout his career, Simonin has collaborated with notable colleagues, including Frédéric Robert and Gérald Deschamps. These collaborations have further enriched his research endeavors, contributing to the development of innovative solutions in capillary electrophoresis.

Conclusion

Denis Simonin stands out as a pioneering inventor in the realm of biochemistry, particularly in the analysis of glycated hemoglobins. His innovative patented methods are not only advancing scientific research but also improving healthcare outcomes. As he continues to develop new technologies, Simonin's contributions will undoubtedly have a lasting impact on the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…